Development and validation of a machine learning model to predict myocardial blood flow and clinical outcomes from patients' electrocardiograms

Cell Rep Med. 2024 Oct 15;5(10):101746. doi: 10.1016/j.xcrm.2024.101746. Epub 2024 Sep 25.

Abstract

We develop a machine learning (ML) model using electrocardiography (ECG) to predict myocardial blood flow reserve (MFR) and assess its prognostic value for major adverse cardiovascular events (MACEs). Using 3,639 ECG-positron emission tomography (PET) and 17,649 ECG-single-photon emission computed tomography (SPECT) data pairs, the ML model is trained with a swarm intelligence approach and support vector regression (SVR). The model achieves a receiver-operator curve (ROC) area under the curve (AUC) of 0.83, with a sensitivity and specificity of 0.75. An ECG-MFR value below 2 is significantly associated with MACE, with hazard ratios (HRs) of 3.85 and 3.70 in the discovery and validation phases, respectively. The model's C-statistic is 0.76, with a net reclassification improvement (NRI) of 0.35. Validated in an independent cohort, the ML model using ECG data offers superior MACE prediction compared to baseline clinical models, highlighting its potential for risk stratification in patients with coronary artery disease (CAD) using the accessible 12-lead ECG.

Keywords: artificial intelligence; coronary artery disease; electrocardiography; machine learning; major adverse cardiovascular events; myocardial blood flow; positron emission tomography.

Publication types

  • Validation Study

MeSH terms

  • Aged
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / physiopathology
  • Coronary Circulation* / physiology
  • Electrocardiography* / methods
  • Female
  • Humans
  • Machine Learning*
  • Male
  • Middle Aged
  • Positron-Emission Tomography / methods
  • Prognosis
  • ROC Curve
  • Tomography, Emission-Computed, Single-Photon / methods